Orthopediatrics Corp (NASDAQ:KIDS) has been assigned a consensus recommendation of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $27.00.
Several research firms recently weighed in on KIDS. BidaskClub upgraded Orthopediatrics from a “sell” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research lowered Orthopediatrics from a “buy” rating to a “hold” rating in a research report on Saturday, November 3rd. Finally, ValuEngine upgraded Orthopediatrics from a “hold” rating to a “buy” rating in a research report on Thursday, August 2nd.
In other Orthopediatrics news, General Counsel Daniel J. Gerritzen sold 9,525 shares of Orthopediatrics stock in a transaction on Wednesday, September 5th. The stock was sold at an average price of $33.73, for a total transaction of $321,278.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kevin Unger sold 1,000 shares of Orthopediatrics stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $33.22, for a total value of $33,220.00. The disclosure for this sale can be found here. 46.10% of the stock is currently owned by insiders.
A number of large investors have recently made changes to their positions in the business. Millennium Management LLC purchased a new position in Orthopediatrics during the first quarter valued at approximately $172,000. Kornitzer Capital Management Inc. KS grew its position in Orthopediatrics by 73.1% during the second quarter. Kornitzer Capital Management Inc. KS now owns 76,000 shares of the company’s stock valued at $2,025,000 after purchasing an additional 32,100 shares in the last quarter. Wasatch Advisors Inc. grew its position in Orthopediatrics by 70.1% during the second quarter. Wasatch Advisors Inc. now owns 401,049 shares of the company’s stock valued at $10,684,000 after purchasing an additional 165,234 shares in the last quarter. Sei Investments Co. purchased a new position in Orthopediatrics during the second quarter valued at approximately $126,000. Finally, EAM Investors LLC purchased a new position in Orthopediatrics during the second quarter valued at approximately $830,000. Institutional investors and hedge funds own 41.25% of the company’s stock.
NASDAQ KIDS opened at $31.69 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 3.23 and a current ratio of 5.67. Orthopediatrics has a twelve month low of $14.00 and a twelve month high of $39.81. The company has a market cap of $383.06 million and a P/E ratio of -5.56.
Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Wednesday, October 31st. The company reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.03). Orthopediatrics had a negative net margin of 55.97% and a negative return on equity of 65.26%. The firm had revenue of $15.82 million for the quarter, compared to the consensus estimate of $15.19 million. During the same quarter in the prior year, the firm earned ($1.70) earnings per share. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. Research analysts predict that Orthopediatrics will post -0.95 EPS for the current fiscal year.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
See Also: What are Institutional Investors?
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.